Sebetralstat Effectiveness in the Treatment of Hereditary Angioedema Attacks Rated Mild or Moderate at Baseline in the Phase 2 Trial

YOU ARE NOW LEAVING KALVISTA.COM

You are now being directed to another KalVista website that contains information about specific treatment(s)